Inclusion Criteria:  Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the informed consent forms; Age greater than or equal to 18 years; Female participants, post-menarche; Clinical diagnosis of vulvovaginal candidiasis, defined as white, fluid or creamy vaginal discharge, in addition to the following findings: Itching and one or more of the following signs and symptoms characterized as moderate or severe: vulvar/vaginal erythema, edema, burning, irritation, and excoriation; Normal vaginal pH; Preparation of KOH or saline from a sample taken from inflamed vaginal mucosa or secretions revealing yeast forms (hyphae or pseudohyphae) or growing yeast.  Exclusion Criteria:  Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of research participants; Participation in a clinical trial in the year prior to this study; Pregnancy or risk of pregnancy and lactating patients; Known hypersensitivity to any of the formula compounds; Virgin participants; Postmenopausal participants or with vaginal atrophy; Participants with other vaginal infections; Participants with recurrent vulvovaginal candidiasis; Participants using immunosuppressive drugs; Participants diagnosed with serious systemic diseases.